| Filed 2020-08-10 12:07 Tx date 2020-08-05 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Options 50 - Grant of options | $1,980,000
+6,000,000 vol
$0.33 each | 10,850,000 | |
| Filed 2020-06-04 08:38 Tx date 2019-12-18 | $RVV
Revive Therapeutics Ltd. | Herman, Joshua Jonathan 4 - Director of Issuer Direct Ownership | Options 00 - Opening Balance-Initial SEDI Report | | 125,334 | |
| Filed 2020-06-04 08:36 Tx date 2019-12-18 | $RVV
Revive Therapeutics Ltd. | Herman, Joshua Jonathan 4 - Director of Issuer Holder: Carly Herman (Control or Direction) | Warrants 00 - Opening Balance-Initial SEDI Report | | 100,000 | |
| Filed 2020-06-04 08:33 Tx date 2019-12-27 | $RVV
Revive Therapeutics Ltd. | Herman, Joshua Jonathan 4 - Director of Issuer Direct Ownership | Options 50 - Grant of options | $35,000
+500,000 vol
$0.07 each | 625,334 | |
| Filed 2020-06-04 08:32 Tx date 2019-12-18 | $RVV
Revive Therapeutics Ltd. | Herman, Joshua Jonathan 4 - Director of Issuer Direct Ownership | Options 00 - Opening Balance-Initial SEDI Report | | | |
| Filed 2020-05-26 11:05 Tx date 2020-03-05 | $RVV
Revive Therapeutics Ltd. | Welsh, Derrick Alexander 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) Direct Ownership | Common Shares 00 - Opening Balance-Initial SEDI Report | | 2,000,000 | |
| Filed 2020-05-25 17:35 Tx date 2020-05-25 | $RVV
Revive Therapeutics Ltd. | Marrelli, Carmelo 5 - Senior Officer of Issuer Direct Ownership | Options 50 - Grant of options |
+500,000 vol | 570,000 | |
| Filed 2020-05-25 17:31 Tx date 2020-05-25 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Options 50 - Grant of options |
+3,000,000 vol | 4,850,000 | |
| Filed 2020-04-22 13:26 Tx date 2020-04-15 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Warrants 16 - Acquisition or disposition under a prospectus exemption |
+1,500,000 vol | 2,000,000 | |
| Filed 2020-04-22 13:24 Tx date 2020-04-15 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Common Shares 16 - Acquisition or disposition under a prospectus exemption | $75,000
+1,500,000 vol
$0.05 each | 2,000,000 | |
| Filed 2020-03-19 07:31 Tx date 2020-03-18 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Warrants 16 - Acquisition or disposition under a prospectus exemption |
+500,000 vol | 500,000 | |
| Filed 2020-03-19 07:29 Tx date 2019-12-18 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Warrants 00 - Opening Balance-Initial SEDI Report | | | |
| Filed 2020-03-19 07:29 Tx date 2020-03-18 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Common Shares 16 - Acquisition or disposition under a prospectus exemption | $25,000
+500,000 vol
$0.05 each | 500,000 | |
| Filed 2020-03-19 07:26 Tx date 2019-12-18 | $RVV
Revive Therapeutics Ltd. | Scovenna, Christian 4 - Director of Issuer Direct Ownership | Common Shares 00 - Opening Balance-Initial SEDI Report | | | |
| Filed 2020-02-11 11:04 Tx date 2020-02-07 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Options 38 - Redemption, retraction, cancellation, repurchase | $-81,250
-250,000 vol
$0.325 each | 1,850,000 | |
| Filed 2020-02-03 14:32 Tx date 2020-02-03 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $1,600
+32,000 vol
$0.05 each | 1,746,500 | |
| Filed 2020-02-03 14:31 Tx date 2020-02-03 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $360.00
+8,000 vol
$0.045 each | 1,714,500 | |
| Filed 2020-01-08 11:36 Tx date 2020-01-07 | $RVV
Revive Therapeutics Ltd. | Leon, Craig 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Options 38 - Redemption, retraction, cancellation, repurchase |
-600,000 vol | 0 | |
| Filed 2020-01-08 11:34 Tx date 2020-01-07 | $RVV
Revive Therapeutics Ltd. | Chianelli, Fabio 3 - 10% Security Holder of Issuer Direct Ownership | Options 38 - Redemption, retraction, cancellation, repurchase |
-275,000 vol | 0 | |
| Filed 2020-01-06 14:30 Tx date 2020-01-06 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $2,200
+40,000 vol
$0.055 each | 1,706,500 | |
| Filed 2020-01-02 11:04 Tx date 2020-01-02 | $RVV
Revive Therapeutics Ltd. | Frank, Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $4,200
+70,000 vol
$0.06 each | 1,666,500 |